Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adial Pharmaceuticals, Inc. (ADIL) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adial Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1513525.
Total stock buying since 2018: $451,114.
Total stock sales since 2018: $948,500.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 700 | $1,918 | 0 | $0 | 0 | $0 |
| 2021 | 55,600 | $150,996 | 350,000 | $375,000 | 0 | $0 |
| 2020 | 44,644 | $59,463 | 350,000 | $423,500 | 0 | $0 |
| 2019 | 73,100 | $238,737 | 150,000 | $150,000 | 0 | $0 |
| 2018 | 212,400 | $0 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 700 | $1,918 | 0 | $0 | 0 | $0 |
| 2021-12 | 25,000 | $67,425 | 0 | $0 | 0 | $0 |
| 2021-11 | 30,600 | $83,571 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 200,000 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 150,000 | $375,000 | 0 | $0 |
| 2020-08 | 0 | $0 | 350,000 | $423,500 | 0 | $0 |
| 2020-03 | 44,644 | $59,463 | 0 | $0 | 0 | $0 |
| 2019-12 | 0 | $0 | 150,000 | $150,000 | 0 | $0 |
| 2019-03 | 73,100 | $238,737 | 0 | $0 | 0 | $0 |
| 2018-07 | 212,400 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-29 | Schuyler Kevin | Buy | 700 | 2.74 | 1,918 |
| 2021-12-30 | Newman James W. Jr. | Buy | 25,000 | 2.70 | 67,425 |
| 2021-11-30 | Stilley William B. Iii (Chief Executive Officer) | Buy | 10,600 | 2.75 | 29,181 |
| 2021-11-29 | Stilley William B. Iii (Chief Executive Officer) | Buy | 10,000 | 2.59 | 25,890 |
| 2021-11-26 | Newman James W. Jr. | Buy | 10,000 | 2.85 | 28,500 |
| 2021-10-04 | Johnson Bankole A. (Chief Medical Officer) | Sale | 200,000 | .00 | 0 |
| 2021-04-06 | Johnson Bankole A. (Chief Medical Officer) | Sale | 150,000 | 2.50 | 375,000 |
| 2020-08-20 | Johnson Bankole A. (Chief Medical Officer) | Sale | 350,000 | 1.21 | 423,500 |
| 2020-03-27 | Newman James W. Jr. | Buy | 19,644 | 1.37 | 26,912 |
| 2020-03-26 | Stilley William B. Iii (Chief Executive Officer) | Buy | 12,652 | 1.47 | 18,598 |
| 2020-03-25 | Stilley William B. Iii (Chief Executive Officer) | Buy | 12,348 | 1.13 | 13,953 |
| 2019-12-12 | Johnson Bankole A. (Chief Medical Officer) | Sale | 150,000 | 1.00 | 150,000 |
| 2019-03-29 | Johnson Bankole A. (Chief Medical Officer) | Buy | 33,100 | 3.41 | 112,937 |
| 2019-03-28 | Johnson Bankole A. (Chief Medical Officer) | Buy | 40,000 | 3.15 | 125,800 |
| 2018-07-31 | En Fidecomiso De Mi Vida 11/23/2010 Trust | Buy | 1,400 | .00 | 0 |
| 2018-07-31 | Newman James W. Jr. | Buy | 20,000 | .00 | 0 |
| 2018-07-31 | Gilliland Robertson H. | Buy | 14,000 | .00 | 0 |
| 2018-07-31 | Schuyler Kevin | Buy | 90,000 | .00 | 0 |
| 2018-07-31 | Stilley William B. Iii (Chief Executive Officer) | Buy | 80,000 | .00 | 0 |
| 2018-07-31 | Goodman Tony | Buy | 7,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADIL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adial Pharmaceuticals, Inc. (symbol ADIL, CIK number 1513525) see the Securities and Exchange Commission (SEC) website.